+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Monkeypox Drug"

From
Monkey Pox Treatment Market Report 2024 - Product Thumbnail Image

Monkey Pox Treatment Market Report 2024

  • Report
  • November 2024
  • 175 Pages
  • Global
From
Monkeypox - Competitive Landscape, 2024 - Product Thumbnail Image

Monkeypox - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Monkeypox is a rare viral infection caused by the monkeypox virus. It is closely related to the smallpox virus, and is found mainly in Central and West African countries. Treatment for monkeypox is similar to that of smallpox, and includes antiviral drugs such as cidofovir, vaccinia immune globulin, and ribavirin. These drugs are used to reduce the severity of the infection and to prevent further spread of the virus. Infectious diseases drugs are used to treat a wide range of illnesses, including monkeypox. The market for these drugs is highly competitive, with many companies offering a variety of treatments. Some of the major players in the monkeypox drug market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. These companies are actively researching and developing new treatments for monkeypox, as well as other infectious diseases. Show Less Read more